Torque Pharmaceuticals

Last updated • 3 min readFrom Wikipedia, The Free Encyclopedia

Torque Pharmaceuticals
Torque Pharmaceuticals Pvt. Ltd.
Formation1985
FounderP.S. Chhatwal
Type private

Torque pharmaceuticals is an Indian pharmaceutical company with production units at Issapur, Derabassi in Punjab and at Jharmajri, Baddi in Himachal Pradesh. It manufactures medicines for prevention and treatment of various health related problems. The product range comprises antibiotics, nutritional supplements and cough syrup to antipyretics and anti-inflammatory products.

Contents

History

Torque Pharmaceuticals was started as a partnership in August 1985 [1] with a small investment of 240,000 INR (US$18000). [1] It started with the production of oral liquids, with manufacturing of tablets starting in 1987. In 1991, after the acquisition of Mac Brown, the manufacturing of small volume parenterals and exports to Uganda commenced. A manufacturing unit was set up at Derabassi, Himachal Pradesh in 1994 and the company was named as Torque Pharmaceuticals Pvt. Ltd., which started the manufacture of parenterals in 2002. In the same year exports to Mozambique and Angola were started. A WHO-GMP Compliance Certificate was awarded by the Drug Regulatory Authorities in the year 2005, as was ISO 9001-2000 certification. The National Drugs Authority (NDA), Uganda certified TORQUE for export of medicines. Another unit was added in Baddi, Himachal Pradesh in 2006.

Under the campaign to promote Torex Cough Syrup, renowned singer Jagjit Singh was chosen as its ambassador in 2007. The next year the company was inspected by Pharmacy and Poisons Board Kenya and subsequently approved. The existing facilities were further expanded in 2010 with acquisition of 200,000 sq. ft. of constructed area in Baddi. More products were launched under the brand name; Ketomac shampoo and No Scars. Next year, other brands were acquired from Ochoa Labs, such as Canstat, Terbofin and Zincoa. The personal care segment was started with introduction of Ketomac Hair Oil in 2012. A year later, the traditional distribution system of its logistical network was changed to DTS. At present, increases in sales volumes are being stressed.

Products

The product range includes Capsule (pharmacy), dry syrups, Injection (medicine), ear drops and eye drops, external preparations (topical medication), oral liquids (Liquid solution or suspension) and Tablet (pharmacy). A range of personal care products such as hair oil and sun screens (sunscreen) are also available.

Founders

The company was launched as a partnership venture with P.S. Chhatwal and A.I.S. BEDI in 1985. Mr.Chhatwal has 36 years of experience in the pharma industry and is a senior member of Himachal Drug Manufacturers Association. Mr. A.I.S. Bedi brings with him the advantage of a science and pharmaceutical background.

Facilities

The company has three units; one in Derabassi and two in Baddi. The unit at Issapur, near Derabassi, Punjab covers an area of almost 1,50,000 sq. ft. and is an export oriented unit with automated machinery and equipment. The unit at Jharmajri, Baddi, Solan is spread over an area of almost 90,000 sq. ft. and caters mostly to the domestic market. Another 40 acres of land have been acquired to set up a textile unit. A textile unit which produces spinning yarn is located here with a capacity of almost 8000 spindles.

Recognition

Torque has been awarded NSIC-CRISIL SE1B [2] credit rating for ‘Highest Performance Capability & Moderate Financial Strength’, NDA (Uganda) Certification, Certification from Pharmacy & Poisons Board (Kenya) and is a member of Basic Chemicals, Pharmaceuticals & Cosmetics Export Promotion Council (CHEMEXCIL), Delhi Chamber of Commerce, Pharmexil and Pharmabiz.

Related Research Articles

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

<span class="mw-page-title-main">Diethylene glycol</span> Chemical compound

Diethylene glycol (DEG) is an organic compound with the formula (HOCH2CH2)2O. It is a colorless, practically odorless, and hygroscopic liquid with a sweetish taste. It is a four carbon dimer of ethylene glycol. It is miscible in water, alcohol, ether, acetone, and ethylene glycol. DEG is a widely used solvent. It can be a normal ingredient in various consumer products, and it can be a contaminant. DEG has also been misused to sweeten wine and beer, and to viscosify oral and topical pharmaceutical products. Its use has resulted in many epidemics of poisoning since the early 20th century.

The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.

<span class="mw-page-title-main">Solan district</span> District of Himachal Pradesh in India

Solan district is one of the twelve districts of the Himachal Pradesh state in northern India. The city of Solan is the administrative headquarters of the district. The district occupies an area of 1936 km2.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Baddi</span> Town in Himachal Pradesh, India

Baddi is an industrial town and Nagar parishad, near Solan City in the southwestern Solan district of Himachal Pradesh, India. The town lies on the border of Himachal Pradesh, Punjab and Haryana states in the Shivalik Hills, around 35 kilometres west of Solan City. Baddi is largest pharmaceutical hub of Asia

<span class="mw-page-title-main">Douglas Pharmaceuticals</span> New Zealand-based pharmaceutical products manufacturer

Douglas Pharmaceuticals Ltd is a New Zealand-based manufacturer of pharmaceutical products. Founded in 1967 by West Auckland chemist Graeme Douglas, the company started out distributing prescription medicines, before manufacturing and later successfully researching and developing its own products for export.

<span class="mw-page-title-main">Actavis</span> Global pharmaceutical company

Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

Dosage forms are pharmaceutical drug products in the form in which they are marketed for use, with a specific mixture of active ingredients and inactive components (excipients), in a particular configuration, and apportioned into a particular dose. For example, two products may both be amoxicillin, but one is in 500 mg capsules and another is in 250 mg chewable tablets. The term unit dose can also sometimes encompass non-reusable packaging as well, although the FDA distinguishes that by unit-dose "packaging" or "dispensing". Depending on the context, multi(ple) unit dose can refer to distinct drug products packaged together, or to a single drug product containing multiple drugs and/or doses. The term dosage form can also sometimes refer only to the pharmaceutical formulation of a drug product's constituent drug substance(s) and any blends involved, without considering matters beyond that. Because of the somewhat vague boundaries and unclear overlap of these terms and certain variants and qualifiers within the pharmaceutical industry, caution is often advisable when conversing with someone who may be unfamiliar with another person's use of the term.

<span class="mw-page-title-main">Pharmaceutical industry in Bangladesh</span>

The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within the country. Manufacturers produce insulin, hormones, and cancer drugs. This sector provides 97% of the total medicinal requirement of the local market. The industry also exports medicines to global markets, including Europe. Pharmaceutical companies are expanding their business with the aim to expand the export market.

Ecology has been given importance in the state during the last few years. Industries becoming the cause of water or air pollution are not encouraged. Every industrial project has to be passed by the clearance of the Environment Protection Organization before its establishment.

Since the 1990s, several mass poisonings from toxic cough syrup have occurred in developing countries. In these cases, an ingredient in cough syrup, glycerine (glycerol), was replaced with diethylene glycol, a cheaper alternative to glycerine for industrial applications. Diethylene glycol is nephrotoxic and can result in multiple organ dysfunction syndrome (MODS), especially in children.

<span class="mw-page-title-main">Drug packaging</span> Packaging for pharmaceutical preparations

Drug packaging is process of packing pharmaceutical preparations for distribution, and the physical packaging in which they are stored. It involves all of the operations from production through drug distribution channels to the end consumer.

Unichem Laboratories is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical formulations across the globe, including the regulated markets of the USA and Europe.

<span class="mw-page-title-main">Grindeks</span> Company based in Riga, Latvia

JSC Grindex, or simply Grindeks, is an internationally operating Latvian pharmaceutical company with headquarters in Riga, Latvia. Its portfolio consists of original products, generics, and active pharmaceutical ingredients. It mostly focuses on cardiovascular, central nervous system, anti-cancer, and diabetes medicines. Grindex is the leading pharmaceutical manufacturer in the Baltic States. In 2021, Grindex imported products to more than 90 countries.

The Pharmacy and Poisons Board is the Drug Regulatory Authority established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya.

The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of APIs locally produced. Pakistani pharmaceutical companies are engaged in importing raw materials, compounding APIs with excipients, coating of pills, and fill-finish activities. The industry is regulated by the Drug Regulatory Authority of Pakistan, which oversees drug approvals and pricing.

<span class="mw-page-title-main">Aurobindo Pharma</span> Indian multinational pharmaceutical company

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.

Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in the manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.

References

  1. 1 2 "From medical representative to Managing Director". The Tribune . 30 November 2002. Retrieved 27 May 2014.
  2. "NSIC-CRISIL Performance and Credit Rating for SSIs". CRISIL . Retrieved 27 May 2014.